ASH 2020 | ASH 2020: CAR-T updates to look out for
Tara Gregory
• 23 Nov 2020
Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO, shares the updates in the CAR-T and cellular therapy field that she is looking forward to at ASH 2020. This includes long-term follow-up results from novel CAR-T therapies such as orvacabtagene autoleucel and ciltacabtagene autoleucel, as well as presentations looking at bispecific CAR-Ts. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
